What the six lenses say about GLAXO — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How GLAXO’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +0.5pp | -1.8pp | +18.1pp | +32.6pp | +23.2pp | +11.6pp |
Nifty 500 Broad-market baseline | +0.4pp | -1.8pp | +17.1pp | +31.0pp | +17.5pp | +6.4pp |
Sector Own-sector index | — | — | +15.7pp | +28.3pp | +8.8pp | -6.9pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
GLAXO daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
GLAXO ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 815 | 1,011 | 949 | 974 | 805 | 980 | 1,041 | 995 |
| ↳ change QoQ | — | +24.1% | -6.1% | +2.6% | -17.4% | +21.7% | +6.2% | -4.4% |
| EBITDA (₹cr) | 266 | 361 | 327 | 333 | 251 | 336 | 371 | 351 |
| EBITDA margin | 32.7% | 35.7% | 34.4% | 34.2% | 31.2% | 34.3% | 35.6% | 35.3% |
| PAT (₹cr) | 182 | 253 | 230 | 263 | 205 | 257 | 296 | 278 |
| ↳ change QoQ | — | +38.5% | -9.0% | +14.4% | -22.1% | +25.4% | +15.2% | -6.1% |
| Net margin | 22.4% | 25.0% | 24.2% | 27.0% | 25.5% | 26.2% | 28.4% | 27.9% |
| EPS (₹) | 10.76 | 14.67 | 13.57 | 15.52 | 12.10 | 15.20 | 17.45 | 16.40 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding GLAXO (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Kotak Large & Midcap Reg Gr | 0.91% | 32,050 | |
| SBI Midcap Reg Gr | 1.31% | 24,354 | |
| ICICI Pru Smallcap Instl Gr | 0.58% | 9,533 | |
| ICICI Pru Smallcap Gr | 0.58% | 9,533 | |
| Nippon India Pharma Gr | 2.66% | 9,279 | |
| Nippon India Pharma Bns | 2.66% | 9,279 | |
| Bajaj Finserv Flexi Cap Reg Gr | 1.09% | 8,173 | |
| Bandhan ELSS Tax saver Reg Gr | 1.04% | 7,005 | |
| Mahindra Manulife Small Cap Reg Gr | 0.59% | 5,087 | |
| Tata Aggressive Hybrid Reg Gr | 2.13% | 3,930 |
ETFs holding GLAXO (3)
| ETF | Weight | Grade |
|---|---|---|
| Mirae Asset Nifty 500 Healthcare ETF | 0.79% | |
| Motilal Oswal BSE Healthcare ETF | 0.67% | |
| Mirae Asset BSE 200 Equal Weight ETF | 0.57% |